PharmaEngine, Inc. operates as a biopharmaceutical company. The Company focuses on the development of new drugs for the treatment of cancer and Asian prevalent diseases.

Announcement Related To The Change Of Business
Location Of The Company'S Stock Affairs Agency "Yuanta
Securities Co., Ltd. Registrar & Transfer Department"

Announcement Of Cancellation Of The Company'S
Restricted Shares For Employees Stock Awards And Change
Of Paid-In Capital Registration

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Pharmaengine Inc (4162 TT)

Announcement Related To The Change Of Business Location Of The Company'S Stock Affairs Agency "Yuanta Securities Co., Ltd. Registrar & Transfer Department"

Announcement Of Cancellation Of The Company'S Restricted Shares For Employees Stock Awards And Change Of Paid-In Capital Registration

Clarification Of Media Reporting

Pharmaengine Obtained Commercial Rights In Taiwan Market For Liporaxel (Paclitaxel Oral Solution)

Board Of Directors Approved The Cancellation Of Restricted Shares To Employees Stock Awards

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)